摘要
目的对照鲑鱼降钙素独用及与仙灵骨葆合用治疗骨质疏松性疼痛的实效性。方法随机选取2013年2月~2014年2月期间无锡市第三人民医院收治的84例骨质疏松患者,通过简单随机分组法均分为2组。治疗组患者接受鲑鱼降钙素和仙灵骨葆合用治疗。对照组患者仅接受鲑鱼降钙素治疗。采用视觉模拟评分法(visual analogue score,VAS)对患者疼痛程度评分。观察并记录2组患者的临床表现和疗效。通过问卷调查统计患者对于治疗的满意程度。结果治疗组患者VAS(visual)评分为(2.17±1.02)。对照组患者VAS评分为(4.26±1.37),2组比较,差异具有统计学意义(P<0.05)。治疗组显效者15例,有效者23例,总有效率为90.48%。对照组显效者10例,有效者19例,总有效率为69.05%,2组比较,差异具有统计学意义(P<0.05)。治疗组患者对于治疗的满意率为95.24%,对照组满意率仅为71.43%,2组比较,差异具有统计学意义(P<0.05)。结论鲑鱼降钙素与仙灵骨葆合用较独用鲑鱼降钙素有更好的临床效果,2者合用可加速患者康复并提高其满意度。
Objective To research and compare the effectiveness distinction between applying exclusive salcatonin and combining salcatonin and Xianling Gubao to treat osteoporotic pain patients. Methods 84 cases of osteoporotic pain patients in our hospital from Feb. 2013 to Feb. 2014 were selected and divided into two groups. Patients in treatment group were received combination of salcatonin and Xianling Gubao treatment. Patients in control group received salcatonin treatment only. To apply VAS judge the pain degree of patients. The clinical performance and results were observed and recorded. The degree of satisfaction of patients was surveyed through questionnaire. Results The VAS of patients in treatment group was( 2. 17 ± 1. 02),while it was( 4. 26 ± 1. 37) in control group. There were 15 cases of excellent,and 23 cases of efficacious in treatment group and the total effective rate was 90. 48%. There were 10 cases of excellent,and 19 cases of efficacious in control group and the total effective rate was 60. 95%. The degree of satisfaction of patients in treatment group was 95. 24%,while it was 71. 43% in control group. Conclusion Combining salcatonin and Xianling Gubao has better clinical effect than applying exclusive salcatonin in treatment of patients with osteoporotic pain. The combination of them could quicken the speed of recovery and increase the degree of satisfaction of patients.
出处
《中国生化药物杂志》
CAS
北大核心
2014年第7期117-119,共3页
Chinese Journal of Biochemical Pharmaceutics
基金
2009博士点基金(20093518120003)
